Article

Surya Singh, MD, Explains the Buy-and-Bill Model

Surya Singh, MD, Vice President, Medical Benefit Management, CVS Caremark, says the buy-and-bill model is most typically applied to the provider space, and more specifically to physicians' offices.

Surya Singh, MD, Vice President, Medical Benefit Management, CVS Caremark, says the buy-and-bill model is most typically applied to the provider space, and more specifically to physicians’ offices. It describes the supply chain for infusion medications, predominately self-injectables that require clinical monitoring, and that are administered or sourced through practitioners.

In this model, buying refers to the procurement of the drugs by the practice, and the billing refers to the bill sent directly to payers.

“There’s been a growth in the number of hospital outpatient centers that source drugs and then bill payers directly through their contracts,” says Dr Singh; “And that’s on the rise given the acquisitions of physician practices in oncology and in other relevant specialties.”

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Pieter Sonneveld, MD, PhD
Mohit Narang, MD
 Sandeep Sahay, MD, FCCP, director of the Pulmonary Hypertension Program, Houston Methodist Hospital
Jessica Horwitz, MPH, FNP-C.
Jessica Horwitz, MPH, FNP-C.
Craig A. Portell, MD, UVA Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo